| 4.15 -0.12 (-2.81%) | 05-01 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 5.78 | 1-year : | 6.75 |
| Resists | First : | 4.94 | Second : | 5.78 |
| Pivot price | 3.58  |
|||
| Supports | First : | 3.27 | Second : | 2.23 |
| MAs | MA(5) : | 4.21 |
MA(20) : | 3.38 |
| MA(100) : | 3.66 |
MA(250) : | 5.25 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 75 |
D(3) : | 79.3 |
| RSI | RSI(14): 61.4 |
|||
| 52-week | High : | 14 | Low : | 2 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ZURA ] has closed below upper band by 22.8%. Bollinger Bands are 62.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 4.32 - 4.35 | 4.35 - 4.37 |
| Low: | 3.86 - 3.88 | 3.88 - 3.91 |
| Close: | 4.11 - 4.15 | 4.15 - 4.19 |
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
Sat, 27 Apr 2024
Zura Bio Limited (NASDAQ:ZURA) Short Interest Update - Defense World
Fri, 26 Apr 2024
Zura Bio Limited (NASDAQ:ZURA) Insider Buys $24999.31 in Stock - Defense World
Thu, 25 Apr 2024
Director Amit Munshi Acquires 159744 Shares of Zura Bio Ltd (ZURA) - GuruFocus.com
Thu, 25 Apr 2024
Director Amit Munshi Acquires 159,744 Shares of Zura Bio Ltd (ZURA) - Yahoo Finance
Wed, 24 Apr 2024
Zura Bio executive acquires $24,999 in company shares By Investing.com - Investing.com
Wed, 24 Apr 2024
Zura Bio EVP Kiran Nistala buys $10000 in company shares - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 44 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 59.4 (%) |
| Held by Institutions | 45.9 (%) |
| Shares Short | 628 (K) |
| Shares Short P.Month | 358 (K) |
| EPS | -2.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.36 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -73.8 % |
| Return on Equity (ttm) | -173.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -15 (M) |
| Levered Free Cash Flow | -25 (M) |
| PE Ratio | -1.99 |
| PEG Ratio | 0 |
| Price to Book value | 3.05 |
| Price to Sales | 0 |
| Price to Cash Flow | -12.02 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|